Back to search

Denmark· DK-28105618315

Porcilis Ery+Parvo+Lepto

A qi09al07 product, registered in Denmark by Intervet International B.V..

ATC QI09AL07

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedPorcilis Ery+Parvo+LeptoATCQI09AL07REGISTER NO.DK-28105618315PACKS LISTED1CHECKEDSeptember 30, 2026

The record

At a glance

Danish Medicines Agency (Denmark)
Manufacturer
Intervet International B.V.
Country
Denmark (DK)
ATC code
QI09AL07
ATC class
QI09AL07
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28105618315

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QI09AL07

Qi09al07, as other registers publish it.

All Porcilis products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/09dc12c9-5968-4462-adcc-0ad7928a017c
GET /v1/drugs/09dc12c9-5968-4462-adcc-0ad7928a017c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, suspension",
  "source": "dkma",
  "strength": "12260",
  "auth_role": "CMS",
  "dk_drugid": "28105618315",
  "substance": null,
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": true,
  "registration_date_serial": "42619"
}

See everything about Porcilis.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.